Risheen Reejhsinghani obtained her medical degree in Mumbai, India, followed by an internal medicine residency at St. Elizabeth's Medical Center in Boston, MA and cardiology fellowship at Baystate Medical Center/Tufts University School of Medicine, where she served as one of the chief fellows. She subsequently completed an advanced echocardiography fellowship at the University of California, San Francisco, and is board certified in echocardiography, general cardiology, and nuclear cardiology.
Dr. Reejhsinghani practices as a general cardiologist in the Division of Cardiovascular Medicine at Stanford University School of Medicine, where she also serves as the associate director for the hospital-based consultative cardiology service. As a clinical cardiologist, she believes strongly in the tenets of evidence-based practice, diagnostic cognizance, and patient education. She also has a specific interest in the burgeoning field of Cardio-Rheumatology, focused on cardiac diseases among patients with rheumatologic conditions such as rheumatoid arthritis, systemic lupus erythematosus, scleroderma, and ankylosing spondylitis, among others. Her clinical research in this area has focused on the evaluation of structural cardiac disease and diastolic dysfunction in ankylosing spondylitis patients, primarily using echocardiography.
Dr. Reejhsinghani has an academic focus in medical education, and believes that instilling a love for bedside medicine and the physical exam is the soundest way to empower future generations of learners. To this end, she received additional training in clinical teaching and simulation at the University of California, San Francisco, and has worked extensively on curriculum and course design. She currently serves as the associate program director of the cardiovascular medicine fellowship at Stanford, and is an associate course director for the Year 1 Practice of Medicine Course at the Stanford University medical school. Dr. Reejhsinghani also enjoys writing, particularly about medical education and has written articles for international newspapers, among other publications.
- Cardiovascular Disease
Associate Program Director, Stanford Cardiovascular Medicine Fellowship (2021 - Present)
Associate Course Director, Practice of Medicine Year 1 Course (2019 - Present)
Associate Director, Consultative Cardiology (2019 - Present)
Boards, Advisory Committees, Professional Organizations
Councilor, Board of Directors, California Chapter, American College of Cardiology (2019 - Present)
Board Certification: American Board of Internal Medicine, Internal Medicine (2023)
Board Certification: Certification Board of Nuclear Cardiology, Nuclear Cardiology (2014)
Fellowship: UCSF Advanced Echocardiography Fellowship (2016) CA
Board Certification: National Board of Echocardiography, Echocardiography (2014)
Board Certification: American Board of Internal Medicine, Cardiovascular Disease (2014)
Fellowship: Baystate Medical Center Cardiovascular Disease Fellowship (2014) MA
Residency: Saint Elizabeth Medical Center Internal Medicine Residency (2011) MA
Medical Education: KJ Somaiya Medical College and Research Center (2006) India
- Perioperative considerations for patients with severe aortic stenosis undergoing elective noncardiac surgery. The American journal of medicine 2023
- Rare Presentation of Paroxysmal High B-Pee. Hypertension (Dallas, Tex. : 1979) 2023
- A change of heart. Journal of hospital medicine 2022
- Perioperative Cardiovascular Considerations Prior to Elective Noncardiac Surgery in Patients With a History of COVID-19. JAMA surgery 1800
CLINICAL CONUNDRUMS IN CARDIO-RHEUMATOLOGY: LIBMAN-SACKS ENDOCARDITIS OF THE PULMONIC VALVE IN SYSTEMIC LUPUS ERYTHEMATOSUS
ELSEVIER SCIENCE INC. 2021: 1877
View details for Web of Science ID 000647487501882
Electrical Storm in COVID-19.
JACC. Case reports
2020; 2 (9): 1256–60
COVID-19 is a global pandemic caused by SARS-CoV-2. Infection is associated with significant morbidity and mortality. Individuals with pre-existing cardiovascular disease or evidence of myocardial injury are at risk for severe disease and death. Little is understood about the mechanisms of myocardial injury or life-threatening cardiovascular sequelae. (Level of Difficulty: Intermediate.).
View details for DOI 10.1016/j.jaccas.2020.05.032
View details for PubMedID 32835266
View details for PubMedCentralID PMC7259914